PredxBio Announces the Presentation of an Explainable AI Platform (TumorMapr™) that Provides a Mechanistic Understanding of the Risk Recurrence in Solid Tumors Using Hyperplexed Fluorescence Data Sets at the American Association for Cancer Research (AACR) Annual Meeting on April 1, 2019.
![](https://predxbio.com/wp-content/uploads/2022/04/LI_220404_AACR-298x300.png)
PredxBio at AACR 2022
PredxBio is ushering a new era of unbiased spatial analytics and explainable AI in precision pathology at AACR 2022 PredxBio announces that it will attend